Sign In
Buy JYNT
$8.23
-0.0400 (-0.484%)
At Close: Jun 04, 2026
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Joint Stock Company Kaspi.kz ("Joint Stock Company Kaspi.kz" or the "Company") (NASDAQ: KSPI) of a class action sec
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19,
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor
11:10am, Monday, 06'th Jan 2025
On Monday, CytoMed Therapeutics GDTC stock is down 6.35% at $3.23 at last check Monday.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
11:00am, Monday, 06'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors a
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
The Gross Law Firm Notifies Joint Stock Company Kaspi.kz Investors of a Class Action Lawsuit and Upcoming Deadline - KSPI
05:45am, Monday, 06'th Jan 2025
NEW YORK , Jan. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). Shareholders who purchased shares of KSPI during
HYOGO, Japan & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TOKYO:4552; “JCR”) and Modalis Therapeutics Corporation (TOKYO:4883; “Modalis”) today announced that they
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
12:00pm, Sunday, 05'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors a
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
Levi & Korsinsky Notifies Joint Stock Company Kaspi.kz Investors of a Class Action Lawsuit and Upcoming Deadline - KSPI
03:15pm, Friday, 03'rd Jan 2025
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securi
NEW YORK CITY, NY / ACCESSWIRE / January 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) between Januar
